FDA Launches Drug Safety Newsletter
(800) 889-9248
This fall the Food and Drug Administration launched a new publication to provide information regarding drug safety. Though the newsletter is primarily intended for healthcare professionals, it is available to anyone who wishes to subscribe.
Each newsletter will contain information on:
- Potential drug risks based on post-marketing reports and clinical trials
- Special interest topics
- Recent drug advisories
One of the primary goals of the agency's newsletter is to raise awareness about adverse events and promote the reporting of such events . The FDA receives over 400,000 reports of drug-related events every year, and it is this information that helps the agency identify drug risks and inform the public.
Individuals are encouraged to report adverse drug events, particularly those that result in serious injury or hospitalization, to MedWatch—the FDA's official adverse event reporting program.
FDA for Consumers
Consumers who would like to stay abreast of the latest news and information on drug safety may also wish to check out some of the other of the FDA's newsletters:
- The Consumer Health Information newsletter is issued every month and contains information about new product approvals, safety news, and related topics.
- The FDA News Digest is published weekly and provides information regarding recent FDA activities, product recalls, and consumer news.
- The Medwatch newsletter allows consumers to receive the latest safety alerts and Class I recalls (life-threatening) for medical devices, drugs, dietary supplements, and cosmetics—as they happen.
- The Recalls newsletter is issued to consumers who wish to know about the latest Class I recalls.
To subscribe to any or all of the FDA's newsletters, visit the FDA website at www.fda.gov . The newsletters are delivered electronically and you can add or remove your name from the listserv at any time.
